|
H6PD expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.017830E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.197380E-01 |
| Normal-vs-Stage2 |
7.634200E-01 |
| Normal-vs-Stage3 |
2.291800E-01 |
| Normal-vs-Stage4 |
4.411000E-01 |
| Stage1-vs-Stage2 |
3.875600E-01 |
| Stage1-vs-Stage3 |
8.886200E-01 |
| Stage1-vs-Stage4 |
2.181400E-01 |
| Stage2-vs-Stage3 |
4.391400E-01 |
| Stage2-vs-Stage4 |
3.482400E-01 |
| Stage3-vs-Stage4 |
1.645440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.100460E-02 |
| Normal-vs-AfricanAmerican |
3.142400E-01 |
| Normal-vs-Asian |
8.004100E-03 |
| Caucasian-vs-AfricanAmerican |
2.727200E-01 |
| Caucasian-vs-Asian |
1.259870E-03 |
| AfricanAmerican-vs-Asian |
3.423500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.644300E-02 |
| Normal-vs-Female |
2.878400E-03 |
| Male-vs-Female |
4.862400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.525400E-01 |
| Normal-vs-Extreme_Weight |
2.414600E-01 |
| Normal-vs-Obese |
1.460320E-02 |
| Normal-vs-Extreme_Obese |
3.583200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.191600E-01 |
| Normal_Weight-vs-Obese |
3.463400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.429200E-01 |
| Extreme_Weight-vs-Obese |
1.629640E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.529200E-01 |
| Obese-vs-Extreme_Obese |
8.298100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.779200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.499300E-03 |
| Normal-vs-Age(61-80Yrs) |
9.386200E-02 |
| Normal-vs-Age(81-100Yrs) |
3.820400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.053600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.656200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.450600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.963600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.459400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.020400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.690140E-02 |
| Normal-VS-Type2 PRCC |
5.820800E-01 |
| Normal-VS-KIRP CIMP |
4.899200E-01 |
| Normal-VS-Unclassified PRCC |
2.375400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.350440E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.659000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.531600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.501200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.922500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.562200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.790600E-01 |
| Normal-vs-N1 |
2.292400E-01 |
| Normal-vs-N2 |
4.443600E-01 |
| N0-vs-N1 |
2.390800E-01 |
| N0-vs-N2 |
4.475000E-01 |
| N1-vs-N2 |
6.300800E-01 |
|
|
